 Fabia Gamboni
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saline Solution, Hypertonic | 4 | 2017 | 59 | 0.880 |
Why?
| | Shock, Hemorrhagic | 7 | 2018 | 241 | 0.610 |
Why?
| | Erythrocyte Transfusion | 4 | 2023 | 210 | 0.600 |
Why?
| | Acute Lung Injury | 6 | 2018 | 311 | 0.590 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 117 | 0.570 |
Why?
| | Erythrocytes | 6 | 2023 | 633 | 0.560 |
Why?
| | Anemia, Sickle Cell | 3 | 2023 | 225 | 0.520 |
Why?
| | Epithelial Cells | 3 | 2017 | 986 | 0.500 |
Why?
| | beta-Thalassemia | 2 | 2023 | 25 | 0.450 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 494 | 0.440 |
Why?
| | Inflammation | 4 | 2018 | 2522 | 0.430 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2023 | 529 | 0.410 |
Why?
| | Signal Transduction | 5 | 2022 | 4810 | 0.360 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2021 | 143 | 0.330 |
Why?
| | Proteome | 2 | 2022 | 363 | 0.320 |
Why?
| | Blood Platelets | 3 | 2019 | 400 | 0.320 |
Why?
| | Metabolome | 2 | 2021 | 307 | 0.310 |
Why?
| | Arachidonate 5-Lipoxygenase | 2 | 2018 | 48 | 0.290 |
Why?
| | Transcriptome | 2 | 2022 | 782 | 0.280 |
Why?
| | Neutrophils | 5 | 2020 | 1252 | 0.270 |
Why?
| | Metabolomics | 5 | 2021 | 545 | 0.270 |
Why?
| | Neoplastic Stem Cells | 3 | 2023 | 341 | 0.250 |
Why?
| | Blood Preservation | 3 | 2022 | 298 | 0.240 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 16 | 0.230 |
Why?
| | Wounds and Injuries | 4 | 2016 | 822 | 0.230 |
Why?
| | Tissue Plasminogen Activator | 2 | 2016 | 254 | 0.230 |
Why?
| | Fibrinolysis | 2 | 2016 | 209 | 0.230 |
Why?
| | Sirtuin 3 | 1 | 2023 | 58 | 0.230 |
Why?
| | Amino Acid Transport System ASC | 1 | 2022 | 10 | 0.220 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2022 | 43 | 0.210 |
Why?
| | Blood | 1 | 2022 | 104 | 0.210 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 57 | 0.200 |
Why?
| | Rats | 9 | 2018 | 5516 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2022 | 124 | 0.200 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2020 | 10 | 0.200 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 36 | 0.200 |
Why?
| | Interferons | 1 | 2022 | 157 | 0.200 |
Why?
| | Cytokines | 3 | 2017 | 1904 | 0.200 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 60 | 0.190 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 189 | 0.190 |
Why?
| | Interleukin-1beta | 3 | 2021 | 382 | 0.190 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 117 | 0.180 |
Why?
| | Biological Products | 1 | 2022 | 163 | 0.180 |
Why?
| | Databases, Genetic | 1 | 2021 | 286 | 0.180 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 170 | 0.180 |
Why?
| | 5-Lipoxygenase-Activating Proteins | 1 | 2018 | 6 | 0.170 |
Why?
| | Animals | 27 | 2023 | 34126 | 0.170 |
Why?
| | Nanoparticles | 1 | 2022 | 327 | 0.170 |
Why?
| | Lung | 5 | 2020 | 3766 | 0.160 |
Why?
| | Protein Kinase C | 2 | 2016 | 306 | 0.160 |
Why?
| | Blood Cells | 1 | 2017 | 41 | 0.160 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 414 | 0.160 |
Why?
| | Antigens, Differentiation | 1 | 2017 | 81 | 0.160 |
Why?
| | Nitriles | 1 | 2018 | 164 | 0.150 |
Why?
| | Macrophages | 3 | 2023 | 1328 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-hck | 1 | 2016 | 6 | 0.150 |
Why?
| | Bronchioles | 1 | 2016 | 24 | 0.150 |
Why?
| | Cryopreservation | 1 | 2017 | 103 | 0.150 |
Why?
| | Proteomics | 4 | 2023 | 885 | 0.150 |
Why?
| | Inflammasomes | 1 | 2018 | 115 | 0.150 |
Why?
| | Interleukin-8 | 1 | 2017 | 251 | 0.150 |
Why?
| | Lysophosphatidylcholines | 1 | 2016 | 33 | 0.150 |
Why?
| | Myeloid Cells | 1 | 2017 | 127 | 0.150 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 91 | 0.140 |
Why?
| | Neutrophil Activation | 1 | 2016 | 100 | 0.140 |
Why?
| | NADPH Oxidases | 1 | 2016 | 142 | 0.140 |
Why?
| | Protein Kinase C-delta | 1 | 2016 | 70 | 0.140 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2016 | 93 | 0.140 |
Why?
| | Humans | 24 | 2023 | 121723 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 7 | 2018 | 2547 | 0.130 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2016 | 366 | 0.130 |
Why?
| | Mice | 9 | 2023 | 15616 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2018 | 461 | 0.120 |
Why?
| | Antibodies | 1 | 2016 | 400 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2018 | 4145 | 0.120 |
Why?
| | Abdominal Injuries | 1 | 2015 | 120 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2016 | 580 | 0.120 |
Why?
| | Multiple Organ Failure | 1 | 2014 | 147 | 0.120 |
Why?
| | Disease Models, Animal | 4 | 2018 | 3798 | 0.120 |
Why?
| | Sodium Channels | 4 | 1996 | 71 | 0.120 |
Why?
| | Prognosis | 1 | 2021 | 3601 | 0.120 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2013 | 177 | 0.110 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2012 | 26 | 0.110 |
Why?
| | Isoflurane | 1 | 2012 | 9 | 0.110 |
Why?
| | Anesthetics, Inhalation | 1 | 2012 | 15 | 0.110 |
Why?
| | Spinal Cord Ischemia | 1 | 2013 | 81 | 0.110 |
Why?
| | Cell Membrane | 1 | 2016 | 717 | 0.110 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 257 | 0.110 |
Why?
| | Mice, Knockout | 4 | 2023 | 2727 | 0.110 |
Why?
| | Blood Transfusion, Autologous | 1 | 2011 | 23 | 0.110 |
Why?
| | Microglia | 1 | 2013 | 218 | 0.100 |
Why?
| | Colonic Neoplasms | 1 | 2013 | 227 | 0.100 |
Why?
| | Datasets as Topic | 2 | 2022 | 109 | 0.100 |
Why?
| | Reperfusion Injury | 1 | 2013 | 279 | 0.100 |
Why?
| | Corpus Luteum | 5 | 1988 | 28 | 0.100 |
Why?
| | Mitochondria | 1 | 2016 | 796 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 340 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2022 | 1970 | 0.100 |
Why?
| | Fatty Acids | 2 | 2023 | 406 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1176 | 0.090 |
Why?
| | Random Allocation | 3 | 2015 | 381 | 0.090 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1403 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2022 | 3314 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 651 | 0.080 |
Why?
| | Disease Progression | 3 | 2023 | 2581 | 0.080 |
Why?
| | Kidney | 1 | 2014 | 1247 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2013 | 833 | 0.070 |
Why?
| | Leukotrienes | 2 | 2018 | 36 | 0.070 |
Why?
| | Hypoxia | 2 | 2023 | 981 | 0.070 |
Why?
| | Axons | 3 | 1994 | 185 | 0.070 |
Why?
| | Cell Survival | 2 | 2022 | 1091 | 0.060 |
Why?
| | Male | 12 | 2021 | 60425 | 0.060 |
Why?
| | Thrombelastography | 2 | 2016 | 251 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 861 | 0.060 |
Why?
| | Hemoglobin, Sickle | 1 | 2023 | 13 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 19 | 0.060 |
Why?
| | Sphingosine | 1 | 2023 | 37 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2016 | 856 | 0.060 |
Why?
| | Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 4 | 0.060 |
Why?
| | Lysophospholipids | 1 | 2023 | 71 | 0.060 |
Why?
| | Injury Severity Score | 2 | 2016 | 544 | 0.060 |
Why?
| | NF-kappa B | 2 | 2017 | 672 | 0.050 |
Why?
| | Trastuzumab | 1 | 2022 | 97 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 376 | 0.050 |
Why?
| | Carnitine | 1 | 2021 | 65 | 0.050 |
Why?
| | Glycolysis | 1 | 2022 | 235 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2022 | 2913 | 0.050 |
Why?
| | Kynurenine | 1 | 2021 | 73 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2022 | 163 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 48 | 0.050 |
Why?
| | Phosphorylation | 2 | 2016 | 1684 | 0.050 |
Why?
| | Hemolysis | 1 | 2022 | 158 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 57 | 0.050 |
Why?
| | Succinic Acid | 1 | 2020 | 51 | 0.050 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 92 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 513 | 0.050 |
Why?
| | Tryptophan | 1 | 2021 | 137 | 0.050 |
Why?
| | Monocytes | 1 | 2023 | 513 | 0.050 |
Why?
| | Niacinamide | 1 | 2020 | 71 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2023 | 479 | 0.050 |
Why?
| | Citric Acid Cycle | 1 | 2019 | 44 | 0.050 |
Why?
| | Blood Donors | 1 | 2021 | 102 | 0.050 |
Why?
| | Data Mining | 1 | 2021 | 139 | 0.050 |
Why?
| | Tumor Cells, Cultured | 1 | 2022 | 907 | 0.050 |
Why?
| | Plateletpheresis | 1 | 2019 | 29 | 0.050 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2019 | 16 | 0.050 |
Why?
| | Plasticizers | 1 | 2019 | 13 | 0.050 |
Why?
| | Homeostasis | 1 | 2023 | 608 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2019 | 47 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 295 | 0.040 |
Why?
| | Myelin Sheath | 2 | 1991 | 146 | 0.040 |
Why?
| | Cold Temperature | 1 | 2019 | 149 | 0.040 |
Why?
| | Estrus | 3 | 1988 | 21 | 0.040 |
Why?
| | Female | 10 | 2023 | 63833 | 0.040 |
Why?
| | Arginine | 1 | 2019 | 261 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 986 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2014 | 1868 | 0.040 |
Why?
| | Purines | 1 | 2019 | 170 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 390 | 0.040 |
Why?
| | Interferon Regulatory Factor-1 | 1 | 2017 | 15 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2021 | 357 | 0.040 |
Why?
| | Chemokine CCL5 | 1 | 2017 | 51 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 503 | 0.040 |
Why?
| | Monitoring, Immunologic | 1 | 2017 | 23 | 0.040 |
Why?
| | Amino Acids | 1 | 2021 | 458 | 0.040 |
Why?
| | Machine Learning | 1 | 2021 | 343 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2017 | 69 | 0.040 |
Why?
| | Adult | 4 | 2021 | 32638 | 0.040 |
Why?
| | Ischemic Preconditioning, Myocardial | 1 | 1997 | 33 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 143 | 0.040 |
Why?
| | Chemotaxis | 1 | 2017 | 135 | 0.040 |
Why?
| | Microcirculation | 1 | 2017 | 154 | 0.040 |
Why?
| | Respiratory Burst | 1 | 2016 | 34 | 0.040 |
Why?
| | Sulfonamides | 1 | 2020 | 458 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2017 | 281 | 0.040 |
Why?
| | Neuroma | 1 | 1996 | 12 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2022 | 869 | 0.040 |
Why?
| | Peripheral Nervous System Neoplasms | 1 | 1996 | 20 | 0.040 |
Why?
| | Cell Separation | 1 | 2017 | 300 | 0.040 |
Why?
| | Leukocytes | 1 | 2017 | 291 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2018 | 229 | 0.040 |
Why?
| | Luteinizing Hormone | 2 | 1988 | 181 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2019 | 704 | 0.040 |
Why?
| | Transfusion Reaction | 1 | 2016 | 79 | 0.040 |
Why?
| | Isoenzymes | 1 | 1997 | 313 | 0.040 |
Why?
| | Cell Nucleus | 2 | 2017 | 598 | 0.040 |
Why?
| | Endothelium | 1 | 2016 | 121 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 707 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 515 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 555 | 0.030 |
Why?
| | Taurocholic Acid | 1 | 2015 | 38 | 0.030 |
Why?
| | Immunohistochemistry | 3 | 2012 | 1732 | 0.030 |
Why?
| | Middle Aged | 3 | 2021 | 28928 | 0.030 |
Why?
| | Protein Transport | 1 | 2016 | 419 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 80 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1194 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1648 | 0.030 |
Why?
| | Peripheral Nerve Injuries | 1 | 1994 | 31 | 0.030 |
Why?
| | Mesentery | 1 | 2014 | 60 | 0.030 |
Why?
| | Sheep | 5 | 1988 | 759 | 0.030 |
Why?
| | Lung Injury | 1 | 2016 | 212 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2017 | 1107 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 2174 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 853 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 265 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 909 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2876 | 0.030 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2012 | 7 | 0.030 |
Why?
| | Doxorubicin | 2 | 1991 | 312 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2016 | 1332 | 0.030 |
Why?
| | Receptors, Purinergic P2 | 1 | 2012 | 22 | 0.030 |
Why?
| | Blood Coagulation Disorders | 1 | 2016 | 260 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2012 | 101 | 0.030 |
Why?
| | Nebulizers and Vaporizers | 1 | 2012 | 81 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2013 | 466 | 0.030 |
Why?
| | Purinergic P2Y Receptor Antagonists | 1 | 2012 | 62 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2012 | 189 | 0.030 |
Why?
| | Ticlopidine | 1 | 2012 | 73 | 0.030 |
Why?
| | Platelet Activation | 1 | 2011 | 72 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 408 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2014 | 468 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 576 | 0.030 |
Why?
| | Down-Regulation | 1 | 2013 | 639 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5296 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 663 | 0.020 |
Why?
| | Protein Binding | 1 | 2016 | 2017 | 0.020 |
Why?
| | Luteal Cells | 2 | 1988 | 4 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 509 | 0.020 |
Why?
| | Calcium | 1 | 2016 | 1207 | 0.020 |
Why?
| | Radioimmunoassay | 3 | 1996 | 177 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2016 | 877 | 0.020 |
Why?
| | Carrier Proteins | 2 | 1991 | 739 | 0.020 |
Why?
| | Resuscitation | 1 | 2012 | 278 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1795 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 633 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 6625 | 0.020 |
Why?
| | Dinoprost | 1 | 1988 | 33 | 0.020 |
Why?
| | Cell Line | 1 | 2014 | 2814 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2012 | 424 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5052 | 0.020 |
Why?
| | Chorionic Gonadotropin | 1 | 1988 | 83 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3079 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2746 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 11215 | 0.020 |
Why?
| | Biomarkers | 1 | 2014 | 3650 | 0.010 |
Why?
| | Microscopy, Electron | 3 | 1988 | 425 | 0.010 |
Why?
| | Goldfish | 2 | 1994 | 32 | 0.010 |
Why?
| | Electrophorus | 2 | 1991 | 4 | 0.010 |
Why?
| | Electric Organ | 2 | 1991 | 11 | 0.010 |
Why?
| | Ranvier's Nodes | 2 | 1991 | 10 | 0.010 |
Why?
| | Tetrodotoxin | 2 | 1991 | 41 | 0.010 |
Why?
| | Luteolysis | 2 | 1988 | 3 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 2 | 1988 | 11 | 0.010 |
Why?
| | Creatine Kinase | 1 | 1997 | 76 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 1997 | 77 | 0.010 |
Why?
| | Coronary Circulation | 1 | 1997 | 132 | 0.010 |
Why?
| | Permeability | 1 | 1997 | 155 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1997 | 560 | 0.010 |
Why?
| | Peripheral Nerves | 1 | 1994 | 65 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1996 | 2113 | 0.010 |
Why?
| | Myocardium | 1 | 1997 | 1010 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1996 | 2948 | 0.010 |
Why?
| | Pain | 1 | 1996 | 745 | 0.010 |
Why?
| | Organ Size | 1 | 1988 | 482 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1986 | 91 | 0.000 |
Why?
| | Progesterone | 1 | 1988 | 248 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1988 | 1137 | 0.000 |
Why?
| | Prolactin | 1 | 1986 | 101 | 0.000 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 1986 | 220 | 0.000 |
Why?
|
|
Gamboni's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|